相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial
Alfredo J. Lucendo et al.
GASTROENTEROLOGY (2019)
RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2019)
Reliability of histologic assessment in patients with eosinophilic oesophagitis
M. J. Warners et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Biological therapies for eosinophilic gastrointestinal diseases
Joshua B. Wechsler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Safety and Efficacy of Reslizumab for Children and Adolescents With Eosinophilic Esophagitis Treated for 9 Years
Jonathan E. Markowitz et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study
Tetsuo Shoda et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Management of refractory eosinophilic oesophagitis
Evan S. Dellon
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Diminishing Effectiveness of Long-Term Maintenance Topical Steroid Therapy in PPI Non-Responsive Eosinophilic Esophagitis
Swathi Eluri et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study
Catherine S. Tripp et al.
ADVANCES IN THERAPY (2017)
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis
Stephan Miehlke et al.
GUT (2016)
Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment
Benjamin P. Davis et al.
JCI INSIGHT (2016)
Predictors of Response to Steroid Therapy for Eosinophilic Esophagitis and Treatment of Steroid-Refractory Patients
W. Asher Wolf et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis
Marc E. Rothenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Eosinophilic Esophagitis
Glenn T. Furuta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Eosinophilic Esophagitis - Treatment of Eosinophilic Esophagitis with Drugs: Corticosteroids
Ulrike von Arnim et al.
DIGESTIVE DISEASES (2014)
Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic Esophagitis
Alain M. Schoepfer et al.
GASTROENTEROLOGY (2014)
Efficacy, Dose Reduction, and Resistance to High-Dose Fluticasone in Patients With Eosinophilic Esophagitis
Bridget K. Butz et al.
GASTROENTEROLOGY (2014)
Allergic Mechanisms in Eosinophilic Esophagitis
Joshua B. Wechsler et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2014)
A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease
Evan S. Dellon et al.
GASTROINTESTINAL ENDOSCOPY (2014)
Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis
J. D. Sherrill et al.
MUCOSAL IMMUNOLOGY (2014)
Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease
Leah C. Kottyan et al.
NATURE GENETICS (2014)
ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)
Evan S. Dellon et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner
Alain M. Schoepfer et al.
GASTROENTEROLOGY (2013)
Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system
Ikuo Hirano et al.
GUT (2013)
Swallowed Fluticasone Improves Histologic but Not Symptomatic Response of Adults With Eosinophilic Esophagitis
Jeffrey A. Alexander et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis
Alex Straumann et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
ChrisA. Liacouras et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Budesonide Is Effective in Adolescent and Adult Patients With Active Eosinophilic Esophagitis
Alex Straumann et al.
GASTROENTEROLOGY (2010)
Oral Viscous Budesonide Is Effective in Children With Eosinophilic Esophagitis in a Randomized, Placebo-Controlled Trial
Ranjan Dohil et al.
GASTROENTEROLOGY (2010)
IL-13 Induces Esophageal Remodeling and Gene Expression by an Eosinophil-Independent, IL-13Rα2-Inhibited Pathway
Li Zuo et al.
JOURNAL OF IMMUNOLOGY (2010)
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: A randomized trial in children
Elizabeth T. Schaefer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids
Carine Blanchard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis
Michael R. Konikoff et al.
GASTROENTEROLOGY (2006)
Topical corticosteroids
B Lebrun-Vignes et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2004)
分享论文
